NCT02400619View on ClinicalTrials.gov

Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2016

Conditions
SpasticityCerebral Palsy
Interventions
DEVICE

shock waves

Swiss dolorclast smart EMS Registration: EN-60601-1 Type BF IP40. 93/42 CEE

DRUG

Botulinum Toxin Type A

Botulinum toxin type A Botox

Trial Locations (1)

08320

Centro Piloto Arcangel Sant Gabriel. ASPACE, Barcelona

All Listed Sponsors
collaborator

Cerebral Palsy Association

OTHER

lead

Xavi Vidal Novellas

OTHER

NCT02400619 - Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT | Biotech Hunter | Biotech Hunter